Diffusion Financial Statements From 2010 to 2024

DFFNDelisted Stock  USD 3.27  0.17  5.48%   
Diffusion Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Diffusion Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Diffusion Pharmaceuticals financial statements helps investors assess Diffusion Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Diffusion Pharmaceuticals' valuation are summarized below:
Diffusion Pharmaceuticals does not presently have any fundamental signals for analysis.
Check Diffusion Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diffusion Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Diffusion financial statements analysis is a perfect complement when working with Diffusion Pharmaceuticals Valuation or Volatility modules.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Diffusion Pharmaceuticals Company Shares Outstanding Analysis

Diffusion Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Diffusion Pharmaceuticals Shares Outstanding

    
  2.04 M  
Most of Diffusion Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diffusion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Diffusion Pharmaceuticals has 2.04 M of shares currently outstending. This is 98.87% lower than that of the Biotechnology sector and 98.09% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.64% higher than that of the company.

Diffusion Pharmaceuticals Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Diffusion Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Diffusion Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diffusion Pharmaceuticals competition to find correlations between indicators driving Diffusion Pharmaceuticals's intrinsic value. More Info.
Diffusion Pharmaceuticals is rated # 4 in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diffusion Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

About Diffusion Pharmaceuticals Financial Statements

Diffusion Pharmaceuticals investors utilize fundamental indicators, such as revenue or net income, to predict how Diffusion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the bodys ability to deliver oxygen. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Diffusion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Pair Trading with Diffusion Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diffusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Diffusion Stock

  0.81PPERY Bank Mandiri PerseroPairCorr
  0.71PPERF Bank Mandiri PerseroPairCorr
  0.69BKRKF PT Bank RakyatPairCorr

Moving against Diffusion Stock

  0.88BAC Bank of America Aggressive PushPairCorr
  0.82CSCO Cisco Systems Aggressive PushPairCorr
  0.81WMT Walmart Aggressive PushPairCorr
  0.79TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.77AXP American Express Fiscal Year End 24th of January 2025 PairCorr
The ability to find closely correlated positions to Diffusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diffusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diffusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diffusion Pharmaceuticals to buy it.
The correlation of Diffusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diffusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diffusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diffusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Diffusion Stock

If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance